(CIDRAP News) – US Health and Human Services (HHS) Secretary Mike Leavitt has announced plans to appoint a 13-member panel to advise him on biodefense issues, including chemical, biological, nuclear, and radiological threats to public health.
(CIDRAP News) An expert panel that advises the Department of Health and Human Services (HHS) today supported the idea of moving quickly on pandemic H1N1 vaccine production with a goal of having "tens of millions of doses" available in September instead of October.
(CIDRAP News) Top state health officials said today they have been kept busy battling rumors and myths about the pandemic H1N1 vaccine, on top of the demanding work of coordinating the vaccination program just getting under way.
(CIDRAP News) In response to questions from citizens at a meeting yesterday, a Food and Drug Administration (FDA) official said the agency would make a decision "fairly soon" about permitting emergency use of the experimental antiviral drug peramivir to help patients severely ill with pandemic H1N1 influenza.
(CIDRAP News) A comprehensive review of the nation's tools for reducing the impact of a biological weapons attack or other public health emergencyprompted in part by last fall's delays in delivery of the pandemic H1N1 vaccineis due to get under way in the next few weeks with a pair of conferences.
(CIDRAP News) A committee that advises the US Department of Health and Human Services on biodefense issues took the first steps today to meet the tough assignment of analyzing the challenges facing HHS's medical countermeasures program and completing a report by Mar 26.
(CIDRAP News) The US government needs much closer collaboration with private industrylike the arrangements used in building aircraft carriers and putting men on the moonin order to improve the nation's medical defenses against biological, chemical, radiological, and nuclear threats, says a report from a federal advisory panel.
(CIDRAP News) The National Biodefense Science Board today capped a hurried review by recommending that the federal government launch a major effort to better focus its activities to develop medical countermeasures (MCMs) for chemical, biological, radiological, and nuclear (CBRN) threats, starting by choosing at least three new countermeasures for priority efforts.